BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18928222)

  • 1. Spinal epidural abscess associated with infliximab treatment for psoriatic arthritis. Case report.
    Smith AP; Musacchio MJ; O'Toole JE
    J Neurosurg Spine; 2008 Sep; 9(3):261-4. PubMed ID: 18928222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteomyelitis occurring during infliximab treatment of severe psoriasis.
    Sri JC; Tsai CL; Deng A; Gaspari AA
    J Drugs Dermatol; 2007 Feb; 6(2):207-10. PubMed ID: 17373180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of recurrent cutaneous abscesses during therapy with infliximab.
    De Simone C; Murri R; Maiorino A; Venier A; Caldarola G
    Clin Ther; 2011 Dec; 33(12):1993-6. PubMed ID: 22088412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical Mycobacterium marinum infection (Aquarium granuloma) in a patient on TNFα antagonist therapy for psoriatic arthritis.
    Ribot E; Poisnel E; De Biasi C; Roudier J; Balandraud N
    Joint Bone Spine; 2014 May; 81(3):272-3. PubMed ID: 24387972
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe bout of cutaneous psoriasis in a patient with psoriasic arthritis undergoing treatment with infliximab.
    Uriarte Itzazelaia E; Hernando I; Prada A; Alonso A
    Clin Exp Rheumatol; 2007; 25(4):659. PubMed ID: 17888230
    [No Abstract]   [Full Text] [Related]  

  • 6. Chest pain as presenting symptom of Staphyloccocus aureus epidural abscess associated with anti-tumor necrosis factor and methotrexate therapy.
    Vasoo S; Gurnani P; Agustin T; Lee J; Singh K
    J Clin Rheumatol; 2009 Dec; 15(8):396-8. PubMed ID: 19955997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical presentation of histoplasmosis in a patient with psoriasis and psoriatic arthritis on infliximab therapy.
    Kamili Qu; Menter A
    J Drugs Dermatol; 2010 Jan; 9(1):57-60. PubMed ID: 20120426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy.
    Lozeron P; Denier C; Lacroix C; Adams D
    Arch Neurol; 2009 Apr; 66(4):490-7. PubMed ID: 19364934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syringotropic hypersensitivity reaction associated with infliximab and leflunomide combination therapy in a child with psoriatic arthritis.
    Vesel T; Luzar B; Calonje E; Avcin T
    J Cutan Pathol; 2009 Sep; 36(9):991-4. PubMed ID: 19017039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infectious risk].
    Calabuig E; Salavert M
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():14-22. PubMed ID: 19080987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour necrosis factor as a therapeutic target in rheumatoid arthritis and other chronic inflammatory diseases: the clinical experience with infliximab (REMICADE).
    Bondeson J; Maini RN
    Int J Clin Pract; 2001 Apr; 55(3):211-6. PubMed ID: 11351775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained clinical response and high infliximab survival in psoriatic arthritis patients: a 3-year long-term study.
    Voulgari PV; Venetsanopoulou AI; Exarchou SA; Alamanos Y; Tsifetaki N; Drosos AA
    Semin Arthritis Rheum; 2008 Apr; 37(5):293-8. PubMed ID: 17888499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy.
    Izzi S; Francesconi F; Visca P; Altieri A; De Mutiis C; Trevisan G; Bonifati C
    Dermatol Online J; 2010 May; 16(5):16. PubMed ID: 20492833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella zoster virus encephalitis during treatment with anti-tumor necrosis factor-alpha agent in a psoriatic arthritis patient.
    Buccoliero G; Lonero G; Romanelli C; Loperfido P; Resta F
    New Microbiol; 2010 Jul; 33(3):271-4. PubMed ID: 20954448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
    Chan CY; Browning JC; Larsen F; Hsu S
    Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of Brucella spondylitis in a patient with psoriatic arthritis receiving infliximab.
    Papagoras CE; Argyropoulou MI; Voulgari PV; Vrabie I; Zikou AK; Drosos AA
    Clin Exp Rheumatol; 2009; 27(1):124-7. PubMed ID: 19327241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lupus like syndrome induced by treatment with anti TNFalpha (infliximab): report of three cases].
    Benucci M; Nenci G; Cappelletti C; Manfredi M
    Recenti Prog Med; 2008; 99(7-8):363-6. PubMed ID: 18751615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optic neuritis in a psoriatic arthritis patient treated by infliximab.
    Minami-Hori M; Tsuji H; Takahashi H; Hanada K; Iizuka H
    J Dermatol; 2013 Apr; 40(4):298-9. PubMed ID: 23289758
    [No Abstract]   [Full Text] [Related]  

  • 20. Psoriasis and psoriatic arthritis induced in a patient treated with infliximab for Crohn's disease.
    Tichy M; Tichy M; Kopova R; Sternbersky J; Ditrichova D
    J Dermatolog Treat; 2012 Jun; 23(3):208-11. PubMed ID: 21254868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.